Immunocore (NASDAQ:IMCR) Sees Large Volume Increase

4 hours ago · Immunocore Holdings plc (NASDAQ:IMCR - Get Free Report) shares saw unusually-high trading volume on Wednesday . Approximately 578,584 shares traded hands during trading, an increase of 100% from the previous session's volume of 288,801 …

100%
OFF

Immunocore (NASDAQ:IMCR) Sees Large Volume Increase

2 weeks from now

marketbeat.com

$1.52
OFF

Immunocore (IMCR) Stock Price, News & Analysis - MarketBeat

2 weeks from now

6 days ago · Average Volume 240,630 shs. Market Capitalization $1.52 billion. P/E Ratio N/A. Dividend Yield N/A. Price Target ... Immunocore Holdings plc (NASDAQ:IMCR) issued its …

marketbeat.com

1%
OFF

Immunocore Plc - IMCR - Stock Price & News | The Motley Fool

2 weeks from now

Immunocore Plc (NASDAQ: IMCR) $29.86 (0.1%) $0.04. Price as of January 3, 2025, 4:00 p.m. ET. Immunocore Plc Return vs. S&P. ... Immunocore Holdings Plc operates as a holding company. The company ...

fool.com

$0.04
OFF

Brokerages Set Immunocore Holdings Plc (NASDAQ:IMCR) Price

2 weeks from now

Jan 5, 2025 · Immunocore Price Performance. Shares of Immunocore stock traded up $0.04 during trading hours on Friday, reaching $29.86. The company's stock had a trading volume of …

marketbeat.com

15%
OFF

IMCR - Immunocore Holdings Plc ADR Stock Price And Quote

2 weeks from now

Avg Volume: 268.28K: Price: 30.40: SMA20: 3.15%: SMA50-2.81%: SMA200-23.38%: Trades: Volume: 312,983: Change: 0.56%: Date ... Immunocore Holdings plc (NASDAQ:IMCR) Ranks …

finviz.com

$27.86
OFF

Immunocore (NASDAQ:IMCR) Reaches New 52-Week Low - Here's …

2 weeks from now

Dec 19, 2024 · Shares of Immunocore Holdings plc (NASDAQ:IMCR - Get Free Report) reached a new 52-week low on Thursday . The company traded as low as $27.86 and last traded at …

marketbeat.com

FAQs about Immunocore (NASDAQ:IMCR) Sees Large Volume Increase Coupon?

Is Immunocore (imcr) a good stock to buy?

Immunocore (IMCR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). ...

Should you buy Immunocore Holdings plc sponsored ADR (imcr)?

Immunocore Holdings PLC Sponsored ADR (IMCR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. The Zacks rating relies solely on a company's changing earnings picture. ...

Where is Immunocore Holdings plc headquartered?

Immunocore Holdings Plc operates as a holding company. The company was founded on January 7, 2021 and is headquartered in Abingdon, the United Kingdom. IMCR - Immunocore Holdings plc ADR - Stock screener for investors and traders, financial visualizations. ...

What will Immunocore holdings' revenue look like in 2024?

Taking into account the latest results, the current consensus from Immunocore Holdings' 16 analysts is for revenues of US$306.6m in 2024. This would reflect a solid 9.2% increase on its revenue over the past 12 months. Per-share losses are expected to explode, reaching US$1.72 per share. ...

Should you buy Immunocore based on rising earnings estimates?

Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Immunocore imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher. Harnessing the Power of Earnings Estimate Revisions ...

Who owns Immunocore stock?

Top institutional shareholders of Immunocore include Wellington Management Group LLP (8.81%), Price T Rowe Associates Inc. MD (6.02%), Bellevue Group AG (1.99%), Fiera Capital Corp (1.73%), and Braidwell LP (1.25%). Immunocore's stock is owned by a variety of institutional and retail investors. ...